Should You Get a P-Tau217 Biomarker Test?
Unable to add items
Add to basket failed.
Add to wishlist failed.
Failed to remove from Wish List.
Adding to library failed
Unable to follow podcast
Unable to unfollow podcast
Should You Get a P-Tau217 Biomarker Test?
-
Narrated by:
-
By:
In this episode of The Truth, Lies & Alzheimer’s Podcast, Lisa Skinner explores the growing conversation around the p-tau217 blood biomarker test and its potential role in identifying Alzheimer’s-related biological changes.
P-tau217 can provide valuable information about the likelihood of Alzheimer’s-related amyloid and tau pathology, but a result is not the same as a dementia diagnosis and cannot predict exactly if or when symptoms will develop.
Lisa discusses:
- What the p-tau217 biomarker test measures
- What a positive or negative result may mean
- Why results should not be viewed as a guarantee or prediction of the future
- The importance of symptoms, medical history, other testing, and clinical evaluation
- Questions to consider before deciding to be tested
- How testing may help provide direction for next steps rather than simply another number
The key question may not be just, “Should I get tested?” but rather, “What am I hoping to learn, and what will I do with the information?”
Hashtags#Alzheimers #Dementia #DementiaCare #PTau217 #AlzheimersResearch #Biomarkers #MemoryLoss #BrainHealth #CognitiveHealth #DementiaAwareness #CaregiverSupport #TheTruthLiesAndAlzheimers
